FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1603040031> ?p ?o ?g. }

• W1603040031 endingPage "1213" @default.
• W1603040031 startingPage "1204" @default.
• W1603040031 abstract "BACKGROUND The objective of this study was to identify trends and predictors of the time to treatment initiation (TTI) for patients with head and neck squamous cell carcinoma (HNSCC). METHODS The National Cancer Database (NCDB) was reviewed for the following head and neck cancer sites: oral tongue, oropharynx, larynx, and hypopharynx. TTI was defined as the number of days from diagnosis to the initiation of definitive treatment and was measured according to covariates. Significant differences in the median TTI across each covariate were measured using the Kruskal‐Wallis test, and the Spearman test was used to measure trends within covariates. For multivariate analysis, a zero‐inflated, negative, binomial regression model was used to estimate the expected TTI, which was expressed in the predicted number of days; and the Vuong test was used to identify the predictors of TTI. RESULTS In total, 274,630 patients were included. Between 1998 and 2011, the median TTI for all patients was 26 days, and it increased from 19 days to 30 days ( P < .0001). Treatment with chemoradiation (CRT) ( P < .0001), treatment at academic facilities ( P < .0001), and stage IV disease ( P < .0001) were associated with increased TTI. TTI significantly increased for each disease stage ( P < .0001), treatment modality ( P < .0001), and facility type ( P < .0001) over time. In addition, patients became more likely to transition care between facilities after diagnosis for treatment initiation ( P < .0001) over time. On multivariate analysis, treatment at academic facilities (33 days), transitioning care (37 days), and receipt of CRT (39 days) predicted for a longer TTI. CONCLUSIONS TTI is rising for patients with HNSCC. Those who have advanced‐stage disease, receive treatment with CRT, are treated at academic facilities, and who have a transition in care realized the greatest increases in TTI. Cancer 2015;121:1204–1213. © 2014 American Cancer Society ." @default.
• W1603040031 created "2016-06-24" @default.
• W1603040031 creator A5002021195 @default.
• W1603040031 creator A5025874222 @default.
• W1603040031 creator A5044353569 @default.
• W1603040031 creator A5048353452 @default.
• W1603040031 creator A5058702476 @default.
• W1603040031 creator A5081121400 @default.
• W1603040031 creator A5084604432 @default.
• W1603040031 date "2014-12-09" @default.
• W1603040031 modified "2023-10-15" @default.
• W1603040031 title "Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database" @default.
• W1603040031 cites W1506816729 @default.
• W1603040031 cites W1547253872 @default.
• W1603040031 cites W1570844233 @default.
• W1603040031 cites W1581365839 @default.
• W1603040031 cites W1603267696 @default.
• W1603040031 cites W1805583869 @default.
• W1603040031 cites W1830719945 @default.
• W1603040031 cites W1909928596 @default.
• W1603040031 cites W1970254246 @default.
• W1603040031 cites W1972090380 @default.
• W1603040031 cites W1977254287 @default.
• W1603040031 cites W2004079062 @default.
• W1603040031 cites W2005216276 @default.
• W1603040031 cites W2006412619 @default.
• W1603040031 cites W2011790890 @default.
• W1603040031 cites W2021514695 @default.
• W1603040031 cites W2024344685 @default.
• W1603040031 cites W2025122048 @default.
• W1603040031 cites W2038390617 @default.
• W1603040031 cites W2042472927 @default.
• W1603040031 cites W2056111356 @default.
• W1603040031 cites W2060574686 @default.
• W1603040031 cites W2071517491 @default.
• W1603040031 cites W2078926128 @default.
• W1603040031 cites W2110311036 @default.
• W1603040031 cites W2120046399 @default.
• W1603040031 cites W2120296730 @default.
• W1603040031 cites W2123508389 @default.
• W1603040031 cites W2125395847 @default.
• W1603040031 cites W2125640401 @default.
• W1603040031 cites W2140110477 @default.
• W1603040031 cites W2143574930 @default.
• W1603040031 cites W2143680521 @default.
• W1603040031 cites W2149155667 @default.
• W1603040031 cites W2152189221 @default.
• W1603040031 cites W2152609192 @default.
• W1603040031 cites W2155304401 @default.
• W1603040031 cites W2169151026 @default.
• W1603040031 cites W2171524637 @default.
• W1603040031 cites W2917561766 @default.
• W1603040031 doi "https://doi.org/10.1002/cncr.29191" @default.
• W1603040031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25490875" @default.
• W1603040031 hasPublicationYear "2014" @default.
• W1603040031 type Work @default.
• W1603040031 sameAs 1603040031 @default.
• W1603040031 citedByCount "103" @default.
• W1603040031 countsByYear W16030400312016 @default.
• W1603040031 countsByYear W16030400312017 @default.
• W1603040031 countsByYear W16030400312018 @default.
• W1603040031 countsByYear W16030400312019 @default.
• W1603040031 countsByYear W16030400312020 @default.
• W1603040031 countsByYear W16030400312021 @default.
• W1603040031 countsByYear W16030400312022 @default.
• W1603040031 countsByYear W16030400312023 @default.
• W1603040031 crossrefType "journal-article" @default.
• W1603040031 hasAuthorship W1603040031A5002021195 @default.
• W1603040031 hasAuthorship W1603040031A5025874222 @default.
• W1603040031 hasAuthorship W1603040031A5044353569 @default.
• W1603040031 hasAuthorship W1603040031A5048353452 @default.
• W1603040031 hasAuthorship W1603040031A5058702476 @default.
• W1603040031 hasAuthorship W1603040031A5081121400 @default.
• W1603040031 hasAuthorship W1603040031A5084604432 @default.
• W1603040031 hasBestOaLocation W16030400311 @default.
• W1603040031 hasConcept C121608353 @default.
• W1603040031 hasConcept C126322002 @default.
• W1603040031 hasConcept C141071460 @default.
• W1603040031 hasConcept C142724271 @default.
• W1603040031 hasConcept C143998085 @default.
• W1603040031 hasConcept C2776530083 @default.
• W1603040031 hasConcept C2776833033 @default.
• W1603040031 hasConcept C2779744641 @default.
• W1603040031 hasConcept C38180746 @default.
• W1603040031 hasConcept C41008148 @default.
• W1603040031 hasConcept C71924100 @default.
• W1603040031 hasConcept C77088390 @default.
• W1603040031 hasConceptScore W1603040031C121608353 @default.
• W1603040031 hasConceptScore W1603040031C126322002 @default.
• W1603040031 hasConceptScore W1603040031C141071460 @default.
• W1603040031 hasConceptScore W1603040031C142724271 @default.
• W1603040031 hasConceptScore W1603040031C143998085 @default.
• W1603040031 hasConceptScore W1603040031C2776530083 @default.
• W1603040031 hasConceptScore W1603040031C2776833033 @default.
• W1603040031 hasConceptScore W1603040031C2779744641 @default.
• W1603040031 hasConceptScore W1603040031C38180746 @default.
• W1603040031 hasConceptScore W1603040031C41008148 @default.
• W1603040031 hasConceptScore W1603040031C71924100 @default.

• next